J&J Vision Unveil Positive Acuvue Oasys Max 1-Day Study Data

The contact lenses are reported to have the highest-level blue-violet filter in the industry.

Katie Hobbins, Managing Editor

October 26, 2022

2 Min Read
contactlens (1).jpg
Image courtesy of Derek Croucher / Alamy Stock Photo

Johnson & Johnson Vision Care, part of Johnson & Johnson Medtech, today presented new positive data of wearing its blue-violet light filtering contact lenses at the 2022 American Academy of Optometry annual meeting.

Acuvue Oasys Max 1-Day contact lenses were designed with a combination of new technologies to help meet the needs of those living digitally intense lifestyles. These new technologies are TearStable Technology and OptiBlue light filter. TearStable Technology is designed to maximize tear-film stability and lock in moisture for all day comfort. The OptiBlue light filter has the highest-level blue-violet filter in the industry at 60%, according to the company, to reduce light scatter for visual clarity in day and night.

The randomized and double-masked study examining the contact lenses included 61 patients who wore a HEV light-filtering contact lens in one eye and a non-HEV light filtering control lens in the other. Patients were exposed to a broadband white light for five seconds and the magnitude of eye squint was measured along with photostress recovery time — the time needed for vision to return to normal following exposure to bright light. Results showed the difference between the two lenses was statistically significant (p < 0.0001) and the HEV light filtering lens had a greater reduction in glare discomfort and photostress recovery time following bright light exposure.

In another randomized, double-masked study, 58 patients who wore a HEV light filtering contact lens in one eye and a non-HEV contact lens in the other were exposed to broadband stimulated sunlight that created the appearance of halos/starbursts. Findings showed that the HEV filtering lens were statistically superior (p < 0.0001) in reducing harmful visual effects of bright light by decreasing light scatter and visual artifacts — starbursts and halos.

The lenses are currently available in both spherical and multifocal.

"As a result of our increasingly digital dependent lifestyles, people are blinking less, which can lead to eye discomfort and a reduced quality of vision," said John Buch, OD, senior principal research optometrist, Johnson & Johnson Vision. "Johnson & Johnson Vision introduced Acuvue Oasys Max 1-Day specifically to address patients' evolving needs and this week we are pleased to reveal data demonstrating how these new lenses can help prolong the tear film and how blue-violet light-filtering can have a positive impact on patients' vision."

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like